MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy and neurological and neuro-ophthalmological impairment that occurs during the second and third decades of life42. Here, MRPL44 is linked to hypertrophic cardiomyopathy.